Larson Financial Group’s Coherus Oncology CHRS Stock Holding History

Larson Financial Group’s Portfolio CHRS Stock Details CHRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$58	Buy
2025 Q1	–	Sell
2024 Q4	$203	Hold
2024 Q3	$153	Sell
2024 Q2	$124K	Sell
2024 Q1	$177K	Buy
2023 Q4	$490	Hold
2023 Q3	$550	Buy
2023 Q2	–	Sell
2023 Q1	$187K	Buy